Unveiling the Future: Lithium Argentina’s Production Results for 2024, 2025 Guidance, and Shareholder Meeting Update

Unveiling the Future: Lithium Argentina’s Production Results for 2024, 2025 Guidance, and Shareholder Meeting Update VANCOUVER, British Columbia, Jan. 08, 2025 (GLOBE NEWSWIRE) Lithium Americas (Argentina) Corp. (“Lithium Argentina” or the “Company”) (TSX: LAAC) (NYSE: LAAC) is pleased to announce its 2024 production results for the Caucharí-Olaroz lithium brine operations

Read More »

URAnium: The Sweet Topping to Your Investment Portfolio

URAnium: The Sweet Topping to Your Investment Portfolio The Growing Positive Sentiment Towards Nuclear Energy There is a growing positive sentiment towards nuclear energy in the investment world. This sentiment is being driven by advancements in safety and the low carbon footprint of nuclear power compared to coal. As the

Read More »

Breaking News: uniQure Sets Record with Successful Public Offering!

Breaking News: uniQure Sets Record with Successful Public Offering! uniQure N.V. announces record-setting public offering LEXINGTON, Mass. and AMSTERDAM, Jan. 08, 2025 (GLOBE NEWSWIRE) — uniQure N.V. (Nasdaq: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced the pricing of its underwritten

Read More »

Breaking Barriers: The T1D Fund Names Elizabeth Mily as CEO to Drive Progress in Type 1 Diabetes Treatment through Impact Investing

Breaking Barriers: The T1D Fund Names Elizabeth Mily as CEO to Drive Progress in Type 1 Diabetes Treatment through Impact Investing Description: Former Bristol Myers Squibb, Goldman Sachs, and Barclays executive brings deep expertise in corporate strategy, partnership development, public and private financial markets, and management as the organization evolves

Read More »

Unlocking Opportunity: Why Tencent’s Recent Blacklist Could be a Smart Investment Move for Politically Neutral Investors

Unlocking Opportunity: Why Tencent’s Recent Blacklist Could be a Smart Investment Move for Politically Neutral Investors Description: In 3Q24, Tencent Holdings Limited (TCEHY) generated RMB 167.2 billion, posting revenue growth of 8.13% y/y and 3.7% q/q. During this period, operating and net margins have expanded while FCF margin remains high.

Read More »

Revolutionizing Transportation: Pony.ai’s Driverless Services to Launch at Hong Kong International Airport and Expand to Urban Areas

Revolutionizing Transportation: Pony.ai’s Driverless Services to Launch at Hong Kong International Airport and Expand to Urban Areas Introduction In a groundbreaking move, Pony.ai, a global leader in autonomous mobility, recently announced its plans to provide driverless transportation services at the Hong Kong International Airport (HKIA), one of the busiest airports

Read More »

Unlocking Hope: BioInvent’s Triple Combo Treatment Shows Promising Results for Non-Hodgkin’s Lymphoma Patients

Unlocking Hope: BioInvent’s Triple Combo Treatment Shows Promising Results for Non-Hodgkin’s Lymphoma Patients LUND, SWEDEN / ACCESSWIRE / January 8, 2025 / BioInvent International (STO:BINV) The first two patients enrolled in the Phase 2a study triplet arm combining BI-1206 with rituximab and Calquence® responded to treatment. One complete response (CR)

Read More »

Breaking News: Exela Technologies Inc. Plans to Delist and Deregister Securities from Nasdaq and the Securities Exchange Act

Breaking News: Exela Technologies Inc. Plans to Delist and Deregister Securities Exela Technologies, Inc. Announces Significant Decision IRVING, Texas, Jan. 07, 2025 (GLOBE NEWSWIRE) — Exela Technologies, Inc. (“Exela” or the “Company”) (OTC: XELA, XELAP), a global business process automation leader, has made a major announcement that will have an

Read More »

Attention Investors: Time is Running Out! Faruqi & Faruqi LLP Investigates Claims for Kyverna Therapeutics Investors

Attention Investors: Time is Running Out! Faruqi & Faruqi LLP Investigates Claims for Kyverna Therapeutics Investors Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Kyverna To Contact Him Directly To Discuss Their Options. If you suffered losses exceeding $50,000 investing

Read More »

Breaking News: uniQure Set to Launch Exciting Public Offering in 2025!

Breaking News: uniQure Set to Launch Exciting Public Offering in 2025! Introduction LEXINGTON, Mass. and AMSTERDAM, Jan. 07, 2025 (GLOBE NEWSWIRE) — uniQure N.V. (Nasdaq: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced that it has commenced an underwritten public offering

Read More »

SEARCH

Receive the latest market news

Subscribe To Our Newsletter

Get notified about market movers